[go: up one dir, main page]

HK1128921B - 4-[5-甲氧基-6-(2-甲基-6-[1，2，4]三唑-1基吡啶-3-基氨基)-嘧啶-4-氧基]-哌啶-1-羧酸異丙酯作為代謝調製器及其相關疾病的治療 - Google Patents

4-[5-甲氧基-6-(2-甲基-6-[1，2，4]三唑-1基吡啶-3-基氨基)-嘧啶-4-氧基]-哌啶-1-羧酸異丙酯作為代謝調製器及其相關疾病的治療 Download PDF

Info

Publication number
HK1128921B
HK1128921B HK09108254.5A HK09108254A HK1128921B HK 1128921 B HK1128921 B HK 1128921B HK 09108254 A HK09108254 A HK 09108254A HK 1128921 B HK1128921 B HK 1128921B
Authority
HK
Hong Kong
Prior art keywords
compound
treatment
diabetes
compounds
compound according
Prior art date
Application number
HK09108254.5A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1128921A1 (zh
Inventor
Robert M. Jones
Juerg Lehmann
Amy Siu-Ting Wong
Original Assignee
Arena Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharmaceuticals, Inc. filed Critical Arena Pharmaceuticals, Inc.
Priority claimed from PCT/US2007/015670 external-priority patent/WO2008005569A2/en
Publication of HK1128921A1 publication Critical patent/HK1128921A1/zh
Publication of HK1128921B publication Critical patent/HK1128921B/zh

Links

HK09108254.5A 2006-07-06 2007-07-05 4-[5-甲氧基-6-(2-甲基-6-[1，2，4]三唑-1基吡啶-3-基氨基)-嘧啶-4-氧基]-哌啶-1-羧酸異丙酯作為代謝調製器及其相關疾病的治療 HK1128921B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81927806P 2006-07-06 2006-07-06
US60/819,278 2006-07-06
PCT/US2007/015670 WO2008005569A2 (en) 2006-07-06 2007-07-05 Modulators of metabolism and the treatment of disorders related thereto

Publications (2)

Publication Number Publication Date
HK1128921A1 HK1128921A1 (zh) 2009-11-13
HK1128921B true HK1128921B (zh) 2010-09-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP2051976B1 (en) 4-[5-methoxy-6-(2-methyl-6-[1,2,4]triazol-1-yl-pyridin-3-ylamino)-pyrimidin-4-yloxy]-piperidine-1-carboxylc acid isopropyl ester as modulator of metabolism and the treatment of disorders related thereto
US20100004272A1 (en) Modulators of metabolism and the treatment of disorders related thereto
EP1931654B1 (en) Modulators of metabolism and the treatment of disorders related thereto
US8362248B2 (en) Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
WO2005007658A2 (en) Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
HK1128921B (zh) 4-[5-甲氧基-6-(2-甲基-6-[1，2，4]三唑-1基吡啶-3-基氨基)-嘧啶-4-氧基]-哌啶-1-羧酸異丙酯作為代謝調製器及其相關疾病的治療
HK1112908B (zh) 新陳代謝調節器和治療其相關疾病
HK1112241B (zh) 以取代吡啶基和嘧啶基的衍生物作新陳代謝調節器及治療其相關的疾病
HK1094542B (zh) 作為新陳代謝調節器的經替代的吡啶和嘧啶衍生物及與新陳代謝相關的疾病的治療